Answers are grounded in this paper and cite their sources.
High-throughput sequencing can detect minimal residual disease comparable to multiparametric flow cytometry in T-ALL patients.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: